Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol. 2009 Aug; 10(8):816-24.

View in: PubMed

subject areas

Adverse Drug Reaction Reporting Systems
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
B-Lymphocytes
Humans
Immunologic Factors
Leukoencephalopathy, Progressive Multifocal
Natalizumab
Rituximab
T-Lymphocytes

authors with profiles

Charles Lee Bennett